The goal of the TANZEUM REMS is to mitigate the potential risk of medullary thyroid carcinoma and the risk of acute pancreatitis associated with TANZEUM by:

• Informing healthcare providers (HCPs) about the potential risk of medullary thyroid carcinoma associated with TANZEUM

• Informing HCPs about the risk of acute pancreatitis associated with TANZEUM